Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (NRF-2020R1F1A1049665).
References
- Islam MR, Hoque MN, Rahman MS, Alam A, Akther M, Puspo JA, Akter S, Sultana M, Crandall KA, Hossain MA. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci Rep. 2020;10:14004. https://doi.org/10.1038/s41598-020-70812-6
- Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020;323:707-8. https://doi.org/10.1001/jama.2020.0757
- Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41:1100-15. https://doi.org/10.1016/j.it.2020.10.004
- Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, Wang Q, Zhou H, Yan J, Qi J. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894-904. https://doi.org/10.1016/j.cell.2020.03.045
- Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Muller MA, Drosten C, Pohlmann S. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271-80. https://doi.org/10.1016/j.cell.2020.02.052
- Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: the current evidence and treatment strategies. Front Immunol. 2020;11:1708. https://doi.org/10.3389/fimmu.2020.01708
- Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY. Freedberg DE, Kirtane AJ, Parikh S, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Pilezikian JPB, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017-32. https://doi.org/10.1038/s41591-020-0968-3
- Redd WD, Zhou JC, Hathorn KE, McCarty TR, Bazarbashi AN, Thompson CC, Shen L, Chan WW. Prevalence and characteristics of gastrointestinal symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection in the United States: a multicenter cohort study. Gastroenterology. 2020;159:765-7. https://doi.org/10.1053/j.gastro.2020.04.045
- Wang W, Xu Y, Gao R, Lu R, Han K, Wu G, Tan. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA. 2020;323:1843-4.
- Chen Y, Chen L, Deng Q, Zhang G, Wu K, Ni L, Yang Y, Liu B, Wang W, Wei C, Yang J, Ye G, Cheng Z. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol. 2020;92:833-40. https://doi.org/10.1002/jmv.25825
- Han MS, Seong MW, Kim N, Shin S, Cho SI, Park H, Kim TS, Park SS, Choi EH. Viral RNA load in mildly symptomatic and asymptomatic children with COVID-19, Seoul, South Korea. Emerg Infect Dis. 2020;26:2497-9. https://doi.org/10.3201/eid2610.202449
- Human Microbiome Project C. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-14. https://doi.org/10.1038/nature11234
- Brooks AW, Priya S, Blekhman R, Bordenstein SR. Gut microbiota diversity across ethnicities in the United States. PLoS Biol. 2018;16:e2006842. https://doi.org/10.1371/journal.pbio.2006842
- Durack J, Lynch SV. The gut microbiome: relationships with disease and opportunities for therapy. J Exp Med. 2019;216:20-40. https://doi.org/10.1084/jem.20180448
- Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, Gibbons SM, Magis AT. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11:5206. https://doi.org/10.1038/s41467-020-18871-1
- Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015;21:8787-803. https://doi.org/10.3748/wjg.v21.i29.8787
- Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019;7:e7502. https://doi.org/10.7717/peerj.7502
- Burchill E, Lymberopoulos E, Menozzi E, Budhdeo S, McIlroy JR, Macnaughtan J, Sharma N. The unique impact of COVID-19 on human gut microbiome research. Front Med. (Lausanne) 2021;8:652464. https://doi.org/10.3389/fmed.2021.652464
- Thevaranjan N, Puchta A, Schulz C, Naidoo A, Szamosi JC, Verschoor CP, Loukov D, Schenck LP, Jury J, Foley KP, Schertzer JD, Larche MJ, Davidson DJ, Verdu EF, Surette MG, Bowdish DM. Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe. 2017;21:455-66. https://doi.org/10.1016/j.chom.2017.03.002
- Gu S, Chen Y, Wu Z, Chen Y, Gao H, Lv L, Guo F, Zhang X, Luo R, Huang C, Lu H, Zheng B, Zhang J, Yan R, Zhang H, Jiang H, Xu Q, Guo J, Gong Y, Tng L, Li L. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin Infect Dis. 2020;71:2669-78. https://doi.org/10.1093/cid/ciaa709
- Zuo T, Zhang F, Lui GCY, Yeoh YK, Li AYL, Zhan H, Wan Y, Chung ACK, Cheung CP, Chen N, Lai CKC, Chen Z, Tso EYK, Fung KSC, Chan V, Ling L, Joynt G, Hui DSC, Chan FKL, Chan PKS, Na SC. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944-55. https://doi.org/10.1053/j.gastro.2020.05.048
- Yeoh YK, Zuo T, Lui GC, Zhang F, Liu Q, Li AY, Chung AC, Cheung CP, Tso EY, Fung KS, Chan V, Ling L, Joynt G, Hui DSC, Chow KM, Ng SSS, Li TCM, Ng RW, Yip TC, Wong GLH, Chan FK, Wong CK, Chan PK, Ng SC. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698-706. https://doi.org/10.1136/gutjnl-2020-323020
- Kim HS. Do an altered gut microbiota and an associated leaky gut affect COVID-19 severity? mBio. 2021;12:e03022-20.
- Din AU, Mazhar M, Waseem M, Ahmad W, Bibi A, Hassan A, Ali N, Gang W, Qian G, Ullah R, Shah T, Ullah M, Khan I, Nisar MF, Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed Pharmacother. 2021;133:110947. https://doi.org/10.1016/j.biopha.2020.110947
- Chhibber-Goel J, Gopinathan S, Sharma A. Interplay between severities of COVID-19 and the gut microbiome: implications of bacterial co-infections? Gut Pathog. 2021;13:14. https://doi.org/10.1186/s13099-021-00407-7
- He Y, Wen Q, Yao F, Xu D, Huang Y, Wang. Gut-lung axis: the microbial contributions and clinical implications. Crit Rev Microbiol. 2017;43:81-95. https://doi.org/10.1080/1040841X.2016.1176988
- Wypych TP, Wickramasinghe LC, Marsland BJ. The influence of the microbiome on respiratory health. Nat Immunol. 2019;20:1279-90. https://doi.org/10.1038/s41590-019-0451-9
- Shen Z, Xiao Y, Kang L, Ma W, Shi L, Zhang L, Zhou Z, Yang J, Zhong J, Yang D, Guo L, Zhang G, Li H, Xu Y, Chen M, Gao Z, Wang J, Ren L, Li M. Genomic diversity of severe acute respiratory syndrome-coronavirus 2 in patients with Coronavirus disease 2019. Clin Infect Dis. 2020;71:713-20. https://doi.org/10.1093/cid/ciaa203
- Fan J, Li X, Gao Y, Zhou J, Wang S, Huang B, Wu J, Cao Q, Chen Y, Wang Z, Luo D, Zhou T, Li R, Shang Y, Nie X. The lung tissue microbiota features of 20 deceased patients with COVID-19. J Infect. 2020;81:e64-7. https://doi.org/10.1016/j.jinf.2020.06.047
- Hoque MN, Rahman MS, Ahmed R, Hossain MS, Islam MS, Islam T, Hossain MA, Siddiki AZ. Diversity and genomic determinants of the microbiomes associated with COVID-19 and non-COVID respiratory diseases. Gene Rep. 2021;23:101200. https://doi.org/10.1016/j.genrep.2021.101200
- De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal microbiota profiling of SARS-CoV-2 infected patients. Biol Proced Online. 2020;22:18. https://doi.org/10.1186/s12575-020-00131-7
- Budding AE, Sieswerda E, Wintermans BB, Bos MP. An age dependent pharyngeal microbiota signature associated with SARS-CoV-2 infection (4/21/2020). Available at SSRN: https://ssrn.com/abstract=3582780 or http://dx.doi.org/10.2139/ssrn.3582780.
- de Oliveira GLV, Oliveira CNS, Pinzan CF, de Salis LVV, Cardoso CRB. Microbiota modulation of the gut-lung Axis in COVID-19. Front Immunol. 2021;12:635471. https://doi.org/10.3389/fimmu.2021.635471
- Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2016;14:20-32. https://doi.org/10.1038/nrmicro3552
- Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodriguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;54:62-75. https://doi.org/10.1016/j.cytogfr.2020.06.001
- Gou W, Fu Y, Yue L, Chen G-D, Cai X, Shuai M, Xu F, Yi X, Chen H, Zhu YJ, Xiao ML, Jiang Z, Miao Z, Xiao C, Shen B, Wu X, Zhao H, Ling W, Wang J, Chen YM, Guo T, Zheng JS. Gut microbiota may underlie the predisposition of healthy individuals to COVID-19. MedRxiv. 2020.
- Zhao Y, Zeng Y, Zeng D, Wang H, Zhou M, Sun N, Xin J, Khalique A, Rajput DS, Pan K, Shu G, Jing B, Ni X. Probiotics and microRNA: their roles in the host-microbe interactions. Front Microbiol. 2020;11:604462.
- Behrouzi A, Ashrafian F, Mazaheri H, Lari A, Nouri M, Riazi Rad F, Hoseini Tavassol Z, Siadat SD. The importance of interaction between MicroRNAs and gut microbiota in several pathways. Microb Pathog. 2020;144:104200. https://doi.org/10.1016/j.micpath.2020.104200
- Nakata K, Sugi Y, Narabayashi H, Kobayakawa T, Nakanishi Y, Tsuda M, Hosono A, Kaminogawa S, Hanazawa S, Takahashi K. Commensal microbiota-induced microRNA modulates intestinal epithelial permeability through the small GTPase ARF4. J Biol Chem. 2017;292:15426-33. https://doi.org/10.1074/jbc.M117.788596
- Rodriguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Garcia F, Olivares M, Rodriguez-Cabezas ME, Galvez J. Differential intestinal anti-inflammatory effects of lactobacillus fermentum and lactobacillus salivarius in DSS mouse colitis: impact on microRNAs expression and microbiota composition. Mol Nutr Food Res. 2017;61:1700144. https://doi.org/10.1002/mnfr.201700144
- Macia L, Nanan R, Hosseini-Beheshti E, Grau GE. Host- and microbiota-derived extracellular vesicles, immune function, and disease development. Int J Mol Sci. 2019;21:107. https://doi.org/10.3390/ijms21010107
- Li M, Chen WD, Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology. Mol Med. 2020;26:101.
- Cullen BR. MicroRNAs as mediators of viral evasion of the immune system. Nat Immunol. 2013;14:205-10. https://doi.org/10.1038/ni.2537
- Aydemir MN, Aydemir HB, Korkmaz EM, Budak M, Cekin N, Pinarbasi E. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways. Gene Rep. 2021;22:101012. https://doi.org/10.1016/j.genrep.2020.101012
- Farshbaf A, Mohtasham N, Zare R, Mohajertehran F, Rezaee SA. Potential therapeutic approaches of microRNAs for COVID-19: challenges and opportunities. J Oral Biol Craniofac Res. 2020;11:132-7.
- Saini S, Saini A, Thakur CJ, Kumar V, Gupta RD, Sharma JK. Genome-wide computational prediction of miRNAs in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) revealed target genes involved in pulmonary vasculature and antiviral innate immunity. Mol Biol Res Commun. 2020;9:83-91.
- Morales L, Oliveros JC, Fernandez-Delgado R, tenOever BR, Enjuanes L, Sola I. SARS-CoV-encoded small RNAs contribute to infection-associated lung pathology. Cell Host Microbe. 2017;21:344-55. https://doi.org/10.1016/j.chom.2017.01.015
- Trobaugh DW, Klimstra WB. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol Med. 2017;23:80-93. https://doi.org/10.1016/j.molmed.2016.11.003
- Fulzele S, Sahay B, Yusufu I, Lee TJ, Sharma A, Kolhe R, Isales CM. COVID-19 virulence in aged patients might be impacted by the host cellular microRNAs abundance/profile. Aging Dis. 2020;11:509-22. https://doi.org/10.14336/ad.2020.0428
- Chow JT, Salmena L. Prediction and Analysis of SARS-CoV-2-targeting microRNA in human lung epithelium. Genes (Basel). 2020;11:1002. https://doi.org/10.3390/genes11091002
- Arisan ED, Dart A, Grant GH, Arisan S, Cuhadaroglu S, Lange S, Uysal-Onganer P. The prediction of miRNAs in SARS-CoV-2 genomes: hsa-miR databases identify 7 key miRs linked to host responses and virus pathogenicity-related KEGG pathways significant for comorbidities. Viruses. 2020;12:614. https://doi.org/10.3390/v12060614
- Li C, Hu X, Li L, Li JH. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J Clin Lab Anal. 2020;34:e23590. https://doi.org/10.1002/jcla.23590
- Marchi R, Sugita B, Centa A, Fonseca AS, Bortoletto S, Fiorentin K, Ferreira S, Cavalli LR. The role of microRNAs in modulating SARS-CoV-2 infection in human cells: a systematic review. Infect Genet Evol. 2021;91:104832. https://doi.org/10.1016/j.meegid.2021.104832
- Khan AT, Khalid Z, Zahid H, Yousaf MA, Shakoori AR. A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets. J Biomol Struct Dyn. 2020;1-17.
- Lu D, Chatterjee S, Xiao K, Riedel I, Wang Y, Foo R, Bar C, Thum T. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J Mol Cell Cardiol. 2020;148:46-9. https://doi.org/10.1016/j.yjmcc.2020.08.017
- Nersisyan S, Shkurnikov M, Turchinovich A, Knyazev E, Tonevitsky A. Integrative analysis of miRNA and mRNA sequencing data reveals potential regulatory mechanisms of ACE2 and TMPRSS2. PLoS One. 2020;15:e0235987. https://doi.org/10.1371/journal.pone.0235987
- Mukhopadhyay D, Mussa BM. Identification of Novel Hypothalamic MicroRNAs as promising therapeutics for SARS-CoV-2 by regulating ACE2 and TMPRSS2 expression: an in silico analysis. Brain Sci. 2020;10:666. https://doi.org/10.3390/brainsci10100666
- Pierce JB, Simion V, Icli B, Perez-Cremades D, Cheng HS, Feinberg MW. Computational analysis of targeting SARS-CoV-2, viral entry proteins ACE2 and TMPRSS2, and interferon genes by host microRNAs. Genes (Basel). 2020;11:1354. https://doi.org/10.3390/genes11111354
- Chang CS, Kao CY. Current understanding of the gut microbiota shaping mechanisms. J Biomed Sci. 2019;26:59. https://doi.org/10.1186/s12929-019-0554-5
- Masotti A. Interplays between gut microbiota and gene expression regulation by miRNAs. Front Cell Infect Microbiol. 2012;2:137. https://doi.org/10.3389/fcimb.2012.00137
- Feng Q, Chen WD, Wang YD. Gut Microbiota: an integral moderator in health and disease. Front Microbiol. 2018;9:151. https://doi.org/10.3389/fmicb.2018.00151
- Casciaro M, Di Salvo E, Pioggia G, Gangemi S. Microbiota and microRNAs in lung diseases: mutual influence and role insights. Eur Rev Med Pharmacol Sci. 2020;24:13000-8.
- Davoodvandi A, Marzban H, Goleij P, Sahebkar A, Morshedi K, Rezaei S, Mahjoubin-Tehran M, Tarrahimofrad H, Hamblin MR, Mirzaei H. Effects of therapeutic probiotics on modulation of microRNAs. Cell Commun Signal. 2021;19:4. https://doi.org/10.1186/s12964-020-00668-w
- Stavropoulou E, Bezirtzoglou E. Probiotics as a weapon in the fight against COVID-19. Front Nutr. 2020;7:614986. https://doi.org/10.3389/fnut.2020.614986
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97. https://doi.org/10.1016/S0092-8674(04)00045-5
- Shimakami T, Yamane D, Jangra RK, Kempf BJ, Spaniel C, Barton DJ, Lemon SM. Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex. Proc Natl Acad Sci U S A. 2012;109:941-6. https://doi.org/10.1073/pnas.1112263109
- Hum C, Loiselle J, Ahmed N, Shaw TA, Toudic C, Pezacki JP. MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs. 2021;81:517-31. https://doi.org/10.1007/s40265-021-01474-5
- Sevgin O, Sevgin K. Systematic review of microRNAs in the SARS-CoV-2 infection: are microRNAs potential therapy for COVID-19? J Genet Genome Res. 2021;8:053.
- Bana B, Cabreiro F. The microbiome and aging. Annu Rev Genet. 2019;53:239-61. https://doi.org/10.1146/annurev-genet-112618-043650
- Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: a review. Clin Immunol. 2020;215:108427. https://doi.org/10.1016/j.clim.2020.108427